Toward extended phenotype matching: A new operational paradigm for the transfusion service

Transfusion

Volumn 50, Issue 3, 2010, Pages 536-546

  Klapper, Ellen ^a   Zhang, Yi ^b   Figueroa, Priscilla ^b   Ness, Paul ^b   Stubbs, James ^b   Abumuhor, Ihab ^b   Bailey, Jeff ^b   Epperson, Laura ^b   Tauscher, Craig ^b   Enriquez, Ermelina ^b   Hashmi, Ghazala ^b   Seul, Michael ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; ERYTHROCYTE ANTIGEN; EXTENDED HUMAN ERYTHROCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ARTICLE; BLOOD COMPATIBILITY; BLOOD TRANSFUSION; COHORT ANALYSIS; DNA DETERMINATION; DNA FINGERPRINTING; DYNAMIC INVENTORY MODEL; HUMAN; MODEL; OBSERVATIONAL STUDY; PHENOTYPE; PHENOTYPE MATCHING; PHENOTYPIC VARIATION; PROSPECTIVE STUDY; RESOURCE ALLOCATION;

ABO BLOOD-GROUP SYSTEM; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; COHORT STUDIES; FEMALE; HEMAGGLUTINATION TESTS; HUMANS; INVENTORIES, HOSPITAL; ISOANTIBODIES; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 77649216386     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02462.x     Document Type: Article

References (13)

1. Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA, van der Schoot CE, van Zwieten R, Roos D, den Dunnen JT, de Haas M. Rapid genotyping of blood cohort antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005 45 : 667 79.
2. Bugert P, McBride S, Smith G, Dugrillon A, Kluter H, Ouwehand WH, Metcalfe P. Microarray-based genotyping for blood cohorts: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005 45 : 654 9.
3. Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005 45 : 660 6.
4. Hashmi G, Shariff T, Seul M, Vissavajjhala P, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Chaudhuri A, Reid ME. A flexible array format for large-scale, rapid blood cohort DNA typing. Transfusion 2005 45 : 680 8.
5. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990 30 : 532 5.
6. Schonewille H, Haak HL, van Zilj AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999 39763 71.
7. Schonewille H, van de Watering L, Brand A. Additional red blood cell alloantibodies after blood transfusions in a non hematologic alloimmunized patient cohort: is it time to take precautionary measures Transfusion 2006 46 : 630 5.
8. Hashmi G, Shariff T, Zhang Y, Cristobal J, Chau C, Seul M, Vissavajjhala P, Baldwin C, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Reid ME. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high throughput DNA analysis. Transfusion 2007 47 : 736 47.
9. Zhang Y, Hashmi G, Seul M, Collins C, Grady M, Sapp C, Long SW, Moulds JM. Randon selection of donor units for extended phenotype determination and efficient allocation to prospective recipients. Transfusion 48 Suppl : 206A.
10. Schonewille H, van de Watering L, Loomans D, Brand A. Red blood cell antibodies after transfusion; factors influencing incidence and specificity. Transfusion 2006 46 : 250 6.
11. Schonewille H, de Vries R, Brand A. Alloimmune response after additional red blood cell antigen challenge inimmunized hematooncology patients. Transfusion 2009 49 : 453 7.
12. U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. Fatalities reported to FDA following blood collection and transfusion; annual summary for fiscal year 2008. Bethesda (MD) : U.S. Food and Drug Administration cited 2009 Aug 21]. Available from: http://www.fda.gov/cber/ blood/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM113649. htm
13. Abumuhor A, Smith L, Klapper E. The value of maintaining special screened RBC inventory by molecular testing in a tertiary care hospital. Transfusion 2009 49 Suppl : 242A.